Northern Trust Corp Lantheus Holdings, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 820,109 shares of LNTH stock, worth $73.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

820,109

Previous 900,287 8.91%

Holding current value

$73.2 Million

Previous $72.3 Million 24.52%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$77.7 - $123.62 $6.23 Million - $9.91 Million	-80,178 Reduced 8.91%	820,109 $90 Million
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $1.46 Million - $2.06 Million	24,779 Added 2.83%	900,287 $72.3 Million
Q1 2024 May 14, 2024	SELL	$51.07 - $68.26 $4.8 Million - $6.41 Million	-93,965 Reduced 9.69%	875,508 $54.5 Million
Q4 2023 Feb 13, 2024	SELL	$55.6 - $77.89 $829,663 - $1.16 Million	-14,922 Reduced 1.52%	969,473 $60.1 Million
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $880,725 - $1.33 Million	-14,613 Reduced 1.46%	984,395 $68.4 Million
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $40,380 - $48,828	490 Added 0.05%	999,008 $83.8 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $170,885 - $296,473	3,578 Added 0.36%	998,518 $82.4 Million
Q4 2022 Feb 13, 2023	BUY	$48.76 - $77.67 $7.54 Million - $12 Million	154,623 Added 18.4%	994,940 $50.7 Million
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $139,669 - $196,223	-2,274 Reduced 0.27%	840,317 $59.1 Million
Q2 2022 Aug 12, 2022	BUY	$55.54 - $72.65 $58,594 - $76,645	1,055 Added 0.13%	842,591 $55.6 Million
Q1 2022 May 13, 2022	SELL	$24.28 - $56.64 $869,806 - $2.03 Million	-35,824 Reduced 4.08%	841,536 $46.5 Million
Q4 2021 Feb 08, 2022	SELL	$22.54 - $30.44 $250,284 - $338,005	-11,104 Reduced 1.25%	877,360 $25.3 Million
Q3 2021 Nov 15, 2021	SELL	$24.23 - $28.59 $280,849 - $331,386	-11,591 Reduced 1.29%	888,464 $22.8 Million
Q2 2021 Aug 13, 2021	BUY	$19.51 - $27.64 $1.33 Million - $1.89 Million	68,232 Added 8.2%	900,055 $24.9 Million
Q1 2021 May 12, 2021	SELL	$13.77 - $21.66 $277,024 - $435,755	-20,118 Reduced 2.36%	831,823 $17.8 Million
Q4 2020 Feb 11, 2021	SELL	$10.75 - $14.91 $296,710 - $411,530	-27,601 Reduced 3.14%	851,941 $11.5 Million
Q3 2020 Nov 16, 2020	SELL	$11.98 - $16.34 $660,253 - $900,546	-55,113 Reduced 5.9%	879,542 $11.1 Million
Q2 2020 Aug 14, 2020	BUY	$10.34 - $15.51 $4.4 Million - $6.6 Million	425,303 Added 83.5%	934,655 $13.4 Million
Q1 2020 May 14, 2020	BUY	$9.11 - $20.05 $37,423 - $82,365	4,108 Added 0.81%	509,352 $6.5 Million
Q4 2019 Feb 14, 2020	SELL	$18.47 - $24.03 $200,990 - $261,494	-10,882 Reduced 2.11%	505,244 $10.4 Million
Q3 2019 Nov 13, 2019	BUY	$21.01 - $28.94 $507,727 - $699,364	24,166 Added 4.91%	516,126 $12.9 Million
Q2 2019 Aug 13, 2019	BUY	$23.33 - $28.3 $180,784 - $219,296	7,749 Added 1.6%	491,960 $13.9 Million
Q1 2019 May 13, 2019	BUY	$14.93 - $25.1 $123,172 - $207,075	8,250 Added 1.73%	484,211 $11.9 Million
Q4 2018 Feb 12, 2019	BUY	$12.68 - $19.01 $34,527 - $51,764	2,723 Added 0.58%	475,961 $7.45 Million
Q3 2018 Nov 14, 2018	BUY	$13.1 - $16.35 $588,425 - $734,409	44,918 Added 10.49%	473,238 $7.08 Million
Q2 2018 Sep 18, 2018	SELL	$13.65 - $18.7 $31,599 - $43,290	-2,315 Reduced 0.54%	428,320 $6.23 Million
Q2 2018 Aug 14, 2018	BUY	$13.65 - $18.7 $1.3 Million - $1.79 Million	95,479 Added 28.49%	430,635 $6.27 Million
Q1 2018 May 09, 2018	SELL	$14.85 - $24.3 $45,604 - $74,625	-3,071 Reduced 0.91%	335,156 $5.33 Million
Q4 2017 Feb 14, 2018	SELL	$17.4 - $23.4 $198,638 - $267,134	-11,416 Reduced 3.27%	338,227 $6.92 Million
Q3 2017 Nov 13, 2017	BUY	$15.5 - $19.15 $5.42 Million - $6.7 Million	349,643	349,643 $6.22 Million

Others Institutions Holding LNTH

# of Institutions

540

Shares Held

68M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Lantheus Holdings, Inc. Transaction History